- NCIt
- C5028
Loading cancer entity…
Loading cancer entity…
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05087849 | Intralesional HPV Vaccine for Condylomata | completed | Phase 1 / Phase 2 | 2 | University of California, San FranciscoOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT05518201 | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | completed | Phase 1 | 90 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT03676101 | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females | completed | Phase 1 | 90 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Jan 22, 2020 | clinicaltrials |
| NCT02748902 | Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. | completed | Phase 1 | 16 | Neal D. Bhatia, MDOTHER | 1 | Jul 17, 2017 | clinicaltrials |
| NCT00851643 | Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) | completed | Phase 1 | 158 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Feb 3, 2016 | clinicaltrials |
| NCT01555112 | Safety and Efficacy Study to Test Topical AS101 for External Genital Warts | completed | Phase 1 / Phase 2 | 12 | BioMAS LtdINDUSTRY | 1 | Aug 15, 2013 | clinicaltrials |
| NCT00499967 | Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts | completed | Phase 1 | 202 | Gilead SciencesINDUSTRY | 1 | Apr 9, 2009 | clinicaltrials |
| NCT00002327 | The Safety and Effectiveness of Cidofovir in the Treatment of Venereal Warts in HIV-Infected Patients | completed | Phase 1 | 40 | Gilead SciencesINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Oct 2, 2025source: clinicaltrials